Science Explorer Back to mapMap
Discussion
Researcher · Singapore General Hospital · Singapore

Charles T. H. Chuah

Charles T. H. Chuah publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research and Acute Lymphoblastic Leukemia research.

ORCID 0000-0002-0834-9333 OpenAlex
World rank
#501,581
of 7,710,434 ranked researchers
Rank in Singapore
#2,977
of 23,642
Works
229
Citations
11k
Citations per work
47.3
h-index
43
i10-index 87Top 5.3% in Hematology
Charles T. H. Chuah

What does Charles T. H. Chuah research?

Charles T. H. Chuah's work is mostly in Medicine (78%), Biochemistry, Genetics and Molecular Biology (9%).

Health Sciences: 177 works · 77.5% of their workMedicine: 177 works · 77.5% of their workHematology: 85 works · 37.1% of their workGenetics: 54 works · 23.5% of their workPublic Health, Environmental and Occupational Health: 18 works · 7.7% of their workRheumatology: 12 works · 5.3% of their workOncology: 9 works · 3.9% of their workEverything else: 32 works · 13.8% of their workLife Sciences: 20 works · 8.7% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 8.7% of their workMolecular Biology: 20 works · 8.7% of their workTHEIR WORKCharles T. H.Chuah229works
Life Sciences9%Health Sciences78%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine17777.5%
  2. Everything else3213.8%
    1. Biochemistry, Genetics and Molecular Biology208.7%
  1. 1Hematology37% of their works
  2. 2Genetics24% of their works
  3. 3Molecular Biology9% of their works
  4. 4Public Health, Environmental and Occupational Health8% of their works
  5. 5Rheumatology5% of their works
  6. 6Oncology4% of their works

Research topics

Which keywords describe Charles T. H. Chuah's research?

The keywords of their largest research topics: Prognostic Factors, BCR-ABL, Imatinib, Chronic Lymphocytic Leukemia, Genomic Aberrations, Acute Lymphoblastic Leukemia, Childhood Cancer and Acute Myeloid Leukemia.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Prognostic Factors2083 topics
  2. BCR-ABL1781 topic
  3. Imatinib1781 topic
  4. Chronic Lymphocytic Leukemia1281 topic
  5. Genomic Aberrations1281 topic
  6. Acute Lymphoblastic Leukemia471 topic
  7. Childhood Cancer471 topic
  8. AML331 topic
  9. Acute Myeloid Leukemia331 topic
  10. Fusion Genes331 topic
  11. Hypereosinophilic Syndrome331 topic
  12. Click Chemistry141 topic
  13. Copper-Catalyzed Cycloaddition141 topic
  14. JAK2 Mutation141 topic
  15. Myelofibrosis141 topic
  16. Signaling141 topic
  17. mTOR141 topic

Where does Charles T. H. Chuah work?

Charles T. H. Chuah's main affiliation in the publication record is Singapore General Hospital, Singapore.

How many publications and citations does Charles T. H. Chuah have?

OpenAlex counts 229 works and 10,824 citations for Charles T. H. Chuah, an h-index of 43, ranking #501,581 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Charles T. H. Chuah. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.